We are live on ! Find out more
BAMF

BI Asset Management Fondsmaeglerselskab Portfolio holdings

AUM $12.6B
1-Year Est. Return 41.69%
This Fund
S&P 500
This Quarter Est. Return
-2.01%
1 Year Est. Return
+41.69%
3 Year Est. Return
+134.93%
5 Year Est. Return
+172.69%
10 Year Est. Return
+588.15%
AUM
$4.3B
AUM Growth
+$82.3M
Cap. Flow
+$227M
Cap. Flow %
5.27%
Top 10 Hldgs %
26.69%
Holding
783
New
45
Increased
320
Reduced
237
Closed
41

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.9M
2
NKE icon
Nike
NKE
+$27.2M
3
NSC icon
Norfolk Southern
NSC
+$22.9M
4
TMO icon
Thermo Fisher Scientific
TMO
+$20.2M
5
MA icon
Mastercard
MA
+$12.1M

Sector Composition

Rank Sector Weight
1 Technology 29%
2 Healthcare 15.31%
3 Financials 12.57%
4 Consumer Discretionary 11.74%
5 Communication Services 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMC icon
626
FMC
FMC
$1.25B
$180K ﹤0.01%
2,681
J icon
627
Jacobs Solutions
J
$16.7B
$179K ﹤0.01%
1,584
WFG icon
628
West Fraser Timber
WFG
$5.5B
$179K ﹤0.01%
2,473
TSN icon
629
Tyson Foods
TSN
$19.8B
$178K ﹤0.01%
3,523
WRB icon
630
W.R. Berkley
WRB
$25.9B
$178K ﹤0.01%
4,214
+1,116
+36% +$46.2K
ERII icon
631
Energy Recovery
ERII
$385M
$174K ﹤0.01%
8,201
+2,029
+33% +$54.2K
CRL icon
632
Charles River Laboratories
CRL
$13.6B
$172K ﹤0.01%
876
FNF icon
633
Fidelity National Financial
FNF
$12.9B
$171K ﹤0.01%
4,137
RGEN icon
634
Repligen
RGEN
$9.39B
$166K ﹤0.01%
1,042
TFX icon
635
Teleflex
TFX
$5.78B
$166K ﹤0.01%
845
FBIN icon
636
Fortune Brands Innovations
FBIN
$5.83B
$165K ﹤0.01%
2,651
-1,620
-38% -$111K
BIO icon
637
Bio-Rad Laboratories Class A
BIO
$9.65B
$163K ﹤0.01%
456
RPM icon
638
RPM International
RPM
$14.4B
$163K ﹤0.01%
1,716
NBIX icon
639
Neurocrine Biosciences
NBIX
$15.5B
$159K ﹤0.01%
1,413
CINF icon
640
Cincinnati Financial
CINF
$26.4B
$158K ﹤0.01%
1,543
CNS icon
641
Cohen & Steers
CNS
$4.34B
$158K ﹤0.01%
2,527
PARA
642
DELISTED
Paramount Global Class B
PARA
$154K ﹤0.01%
11,941
GDDY icon
643
GoDaddy
GDDY
$11.6B
$152K ﹤0.01%
2,041
ZBRA icon
644
Zebra Technologies
ZBRA
$17.8B
$151K ﹤0.01%
639
-785
-55% -$213K
JNPR
645
DELISTED
Juniper Networks
JNPR
$150K ﹤0.01%
5,388
-5,725
-52% -$165K
TCN
646
DELISTED
Tricon Residential Inc.
TCN
$149K ﹤0.01%
20,177
APA icon
647
APA Corp
APA
$14B
$148K ﹤0.01%
3,605
L icon
648
Loews
L
$23B
$148K ﹤0.01%
2,339
CSGP icon
649
CoStar Group
CSGP
$12.5B
$145K ﹤0.01%
1,886
-4,731
-71% -$392K
MSI icon
650
Motorola Solutions
MSI
$76.4B
$145K ﹤0.01%
+532
New +$152K

Similar funds

BI Asset Management Fondsmaeglerselskab's Q3 2023 Portfolio in Review

As of Q3 2023, BI Asset Management Fondsmaeglerselskab held 783 positions worth $4.3B, up 1.9% from $4.22B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

BI Asset Management Fondsmaeglerselskab deployed $227M of net new capital in Q3 2023, opening 45 new positions and adding to 320 existing holdings. Its largest new stake was Tenet Healthcare: 69,122 shares worth $4.55M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Merck, an estimated $43.9M trimmed.

  • BI Asset Management Fondsmaeglerselskab's largest Q3 2023 buy was Tenet Healthcare: 69,122 shares worth $4.55M.
  • BI Asset Management Fondsmaeglerselskab added most to Meta Platforms (Facebook) in Q3 2023, an estimated $36.4M increase.
  • BI Asset Management Fondsmaeglerselskab's biggest Q3 2023 reduction was Merck, cutting an estimated $43.9M.
  • BI Asset Management Fondsmaeglerselskab fully exited Gold Fields in Q3 2023, selling an estimated $4.26M.
  • BI Asset Management Fondsmaeglerselskab's ten largest holdings make up 27% of its $4.3B portfolio in Q3 2023.
  • BI Asset Management Fondsmaeglerselskab opened 45 new positions and closed 41 in Q3 2023.
  • BI Asset Management Fondsmaeglerselskab's portfolio value rose 1.9% quarter-over-quarter to $4.3B.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q3 2023, filed 13 Nov 2023.